Tobacco smoking

Global Smoking Cessation Aids Market Forecast to 2028 - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 17, 2021
Tobacco, Retail, Online, Industry, VIP, CAGR, Tobacco smoking, British American Tobacco, Growth, Smoking, Nicotine polacrilex, Smoker, American Tobacco Company, Juul, Pharmacy, World Health Organization, Hospital, Time, BAT, World, Risk, Public health, WHO, Patient, GlaxoSmithKline, Laboratory, Smoke, GSK, COVID-19, Mucus, Tobacco, Marketing

Based on end-user, the smoking cessation aids market is segmented into hospital pharmacies, online channel, retail pharmacies, and other end users.

Key Points: 
  • Based on end-user, the smoking cessation aids market is segmented into hospital pharmacies, online channel, retail pharmacies, and other end users.
  • Furthermore, the top players in the market are also collaborating with third parties to improve their existing product range of smoking cessation aids.
  • Thus, the consistent launch of new and innovative smoking cessation aids would become a prevalent trend in the smoking cessation aids market in the coming years.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Global Oxygen Concentrator Market Overview 2020-2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021
Medical Devices, Health, Degenerative disease, Oxygen, Invacare, Government, CAGR, COVID-19, Coronavirus, Patient, Growth, ResMed, Medicare, Tobacco smoking, USD, Prevalence, Hospital, Pharmaceutical industry

The "Global Oxygen Concentrator Market Overview, 2020-26" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Oxygen Concentrator Market Overview, 2020-26" report has been added to ResearchAndMarkets.com's offering.
  • The oxygen concentrator provides for such a condition thereby creating a sudden boost in the market.
  • The global oxygen concentrator market is expected to grow over an impressive CAGR of over 6% through the forecasted period.
  • Some of the prominent players operating in the medical oxygen concentrators market include Teijin Limited, Nidek Medical Products, Inogen, ResMed, and Invacare Corporation among other players.

Global Capnography Market (2021 to 2026) - Featuring DiMedica, Masimo and Medtronic Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 10, 2021
Medical Devices, Health, Adoption, Respiratory disease, Health Promotion International, Stroke, Tobacco smoking, Medtronic, Patient, Pressure, Urinary tract infection, Efficiency, Physician, Lung cancer, Carbon, Smoking, Technology, CVD, Cardiovascular disease, Asthma, WHO, Lists of countries and territories, Ambulance, Ventricular septal defect, COVID-19, Prevalence, COPD, Fatality, Degenerative disease, Critical care, Fortis Healthcare, CHD, Cardiology, Growth, Spine, Pharmaceutical industry

Capnography displays exhaled carbon dioxide as a waveform to show the quantity of carbon dioxide present at each stage of the respiratory cycle.

Key Points: 
  • Capnography displays exhaled carbon dioxide as a waveform to show the quantity of carbon dioxide present at each stage of the respiratory cycle.
  • Growing advancement in technology is one of the key factors driving the Capnography market.
  • Chronic respiratory diseases are found affecting the airways and other parts of the lungs for a longer duration of the period.
  • During the COVID-19 pandemic, market players such as Medtronic experienced a surge in the demand for capnography devices, among other respiratory system-related products.

Israel HNB, Oral Tobacco and Nicotine Pouches Regulatory Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021
Tobacco, Retail, Tobacco, Psychoactive drugs, Cigarettes, Electronic cigarettes, Tobacco control, Smoking cessation, Electronic cigarette, Tobacco smoking, Cigarette, Regulation of electronic cigarettes, Plain tobacco packaging

The "Regulatory Report: Israel - HNB, Oral Tobacco and Nicotine Pouches" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: Israel - HNB, Oral Tobacco and Nicotine Pouches" report has been added to ResearchAndMarkets.com's offering.
  • At the end of 2018, the Israeli parliament, the Knesset, amended the Law on Prohibition of Advertising and Restriction of Marketing of Tobacco and Smoking Products, which was signed into law on 8th January 2019.
  • The provisions of the new law were organised to come into force in four stages; since June 2020 all of the law's provisions are now applicable.
  • It notably brings restrictions for alternative tobacco products in Israel - including heated tobacco and e-cigarettes - in line with those for traditional cigarettes in the areas of public use, packaging and labelling, and advertising, and imposes additional restrictions on the product itself.

Tobacco products worth more than € 2 million seized in Spain and Portugal

Retrieved on: 
Wednesday, July 14, 2021
Psychoactive drugs, Tobacco, Cigarettes, Illicit cigarette trade, Smuggling, Tobacco control, Cigarette, Cigar, Tobacco smoking, Regulation of electronic cigarettes

The action day on 7 July 2021 led to:

Key Points: 
  • The action day on 7 July 2021 led to:

    About 3.2 million in tobacco products seized since the investigation was launched

    The criminal network was involved in the illegal import of large quantities of tobacco leaves and strips from Spain into Portugal.

  • This raw material served the illegal production of both cigarettes and tobacco for roll-your-own-cigarettes distributed on the Portuguese black market.
  • The tobacco processed there was shipped to Portugal, where it was stored in different warehouses before being further distributed.
  • Since the investigation was launched in May 2020, the Portuguese and the Spanish authorities have detained 23 individuals and seized about 1.8 million illicit cigarettes along with 11 tons of tobacco, all of which was worth about 3.2 million.

Pivot's Breath Sensor Receives Expanded Indications for Use from FDA

Retrieved on: 
Monday, July 12, 2021
Human behavior, Habits, Health, Health effects of tobacco, Drug rehabilitation, General practice, Smoking cessation, Food and Drug Administration, Smoking, Sensor, Tobacco smoking

As the only over-the-counter, FDA-cleared breath sensor for smoking cessation, Pivots Carbon Monoxide Breath Sensor provides innovative technology that goes beyond measuring the impact of smoking cessation: The sensor has now been proven to increase a persons motivation to quit.

Key Points: 
  • As the only over-the-counter, FDA-cleared breath sensor for smoking cessation, Pivots Carbon Monoxide Breath Sensor provides innovative technology that goes beyond measuring the impact of smoking cessation: The sensor has now been proven to increase a persons motivation to quit.
  • The new FDA clearance allows Carrot to highlight this expanded indication in its labeling and promotion of the sensor.
  • The emergence of an over-the-counter breath sensor that can help people quit tobacco is comparable to when consumer grade glucose meters became available, empowering people in their own diabetes care.
  • In the clinical trial supporting the expanded indications of the Pivot Breath Sensor, Carrot tested the device with 234 heavy tobacco users.

Worldwide Pulmonary Drugs Industry to 2026 - Rising Prevalence of Pulmonary Diseases is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021
Pharmaceutical, Health, Cardiology, Human behavior, Habits, Articles, Life sciences, Biotechnology, Drug culture, Smoking, Tobacco smoking, Biosimilar, Tobacco

The Global Pulmonary Drugs Market is estimated to be USD 56.9 Bn in 2021 and is expected to reach USD 67.6 Bn by 2026, growing at a CAGR of 3.5%.

Key Points: 
  • The Global Pulmonary Drugs Market is estimated to be USD 56.9 Bn in 2021 and is expected to reach USD 67.6 Bn by 2026, growing at a CAGR of 3.5%.
  • The factors that are driving the market include the rising prevalence of pulmonary diseases and the growing geriatric population.
  • With the entry of innovative drugs into the markets, there is an increased scope for market growth.
  • Government and non-government initiatives, and the availability of biosimilars, increasing tobacco smoking are fuelling the market growth.

Proposed ban on vaping flavours will push Canadians back to smoking traditional cigarettes, admits Health Canada's own report

Retrieved on: 
Tuesday, July 6, 2021
Electronic cigarettes, Tobacco, Cigarettes, Smoking, Electronic cigarette, Cigarette, Smoking cessation, Tobacco smoking, Positions of medical organizations on electronic cigarettes, Vaping lung illness outbreak

TORONTO, July 6, 2021 /CNW/ - In an unprecedented move, Health Canada is proposing a full federal ban on vaping flavours.

Key Points: 
  • TORONTO, July 6, 2021 /CNW/ - In an unprecedented move, Health Canada is proposing a full federal ban on vaping flavours.
  • "This is not me editorializing or being sarcastic, this is what the report commissioned by Health Canada says.
  • The report freely admits that Canadians are likely to resume smoking cigarettes if vaping flavours are banned," adds Mr. Bekman.
  • "How would banning vaping flavours help Canadians who are trying to quit smoking?"

Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2a Study of EMB-001 in Smoking Cessation

Retrieved on: 
Wednesday, June 30, 2021
Health, FDA, Other Health, General Health, Clinical trials, Pharmaceutical, Cardiology, Psychoactive drugs, Human behavior, Smoking, Health, Health effects of tobacco, Habits, Substance dependence, Drug rehabilitation, Smoking cessation, Addiction, Tobacco smoking, Nicotine Anonymous, EMB-001, Embera NeuroTherapeutics, EMB-001, EMBERA NEUROTHERAPEUTICS

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and potentially other addictions, today announced that the first subject has been dosed in a Phase 2a smoking cessation study for the treatment of tobacco use disorder.

Key Points: 
  • Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and potentially other addictions, today announced that the first subject has been dosed in a Phase 2a smoking cessation study for the treatment of tobacco use disorder.
  • In a Phase 1 Safety study, EMB-001 was well-tolerated and signals of efficacy were observed.
  • This Phase 2a study will help us better understand the efficacy of EMB-001 in helping subjects stop smoking.
  • Current investors in Embera participated in a $1.3 million financing to support the EMB-001 Phase 2a tobacco use disorder clinical study.

Global Hookah Tobacco Market 2021-2025 - Increasing Frequency of New Flavour Launches - ResearchAndMarkets.com

Retrieved on: 
Monday, June 28, 2021
Tobacco, Retail, Psychoactive drugs, Tobacco, Arab culture, Tobacco smoking, Pipe smoking, Drugs, Leaves, Hookah, Retail

The "Global Hookah Tobacco Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hookah Tobacco Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The hookah tobacco market is poised to grow by USD 376.43 million during 2021-2025, progressing at a CAGR of almost 3% during the forecast period.
  • The market is driven by the increasing frequency of new flavour launches and rising number of organized retailing outlets.
  • Ltd. Also, the hookah tobacco market analysis report includes information on upcoming trends and challenges that will influence market growth.